Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07208435
Starting soon Not applicable

Web-Based Exercise Program for Non-Specific Low Back Pain

NCT07208435 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05
Last updated
2026-05-19

Condition(s) studied

Non-specific Low Back Pain (NSLBP)

Investigational drug(s) / intervention(s)

Web-Based Therapeutic Exercise ProgramTraditional Home Exercise Program

Web-Based Therapeutic Exercise Program: Participants complete an 8-week web-based therapeutic exercise program via Physitrack, with 30-45 minute sessions twice weekly. The program targets core strengthening, spinal mobility, posture correction, and pain reduction. Exercises progress weekly from basic core engagement and breathing techniques to advanced trunk control, dynamic movements, and integration. The platform provides instructional videos, reminders, educational content, and self-monitoring tools to enhance adherence, engagement, and self-management.

Traditional Home Exercise Program: Participants follow a 6-week traditional home exercise program with 30-40 minute sessions, twice weekly. The program focuses on flexibility, basic trunk and core strengthening, balance, and ergonomic practice. Exercises progress weekly, including cat-cow stretches, pelvic tilts, glute bridges, partial curl-ups, bird-dog, lunges, and posture training. Participants perform exercises independently at home using printed instructions, aiming to reduce pain, improve spinal mobility, and enhance functional outcomes.

Study summary

This study evaluates the effectiveness of a web application-based exercise program (delivered via Physitrack) for managing non-specific low back pain (NSLBP) compared to traditional home exercise programs. The trial focuses on whether web-based delivery can improve pain, function, quality of life, and adherence, providing evidence for digital rehabilitation as a practical alternative to conventional physiotherapy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18-45 years diagnosed with non-specific low back pain (NSLBP) for 6 weeks to \<12 months. * Self-reported pain intensity ≥3 on a 0-10 Numeric Pain Rating Scale (NPRS). * Evidence of functional limitation (Oswestry Disability Index or Roland-Morris Disability Questionnaire). * Access to a smartphone, tablet, or computer with internet connectivity. * Ability and willingness to participate in telerehabilitation programs. Exclusion Criteria: * Specific causes of low back pain (herniated disc with radiculopathy, spinal stenosis, spondylolisthesis, fractures, infections, malignancy). * Neurological deficits (e.g., severe motor weakness, progressive neurological symptoms). * Severe psychiatric or cognitive disorders interfering with participation. * History of spinal surgery within the last year. * Severe comorbidities contraindicating exercise (e.g., uncontrolled diabetes, cardiovascular disease). * Pregnant or planning pregnancy during the study period. * Active substance or alcohol abuse. * Participation in other structured rehabilitation or physical therapy programs within the last 3 months.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Medipol University Istanbul Beykoz

More Medipol University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07208435 on ClinicalTrials.gov ↗ ← All trials in Turkey